Entresto 97 MG-103 MG tablet 180S
Ended Awarded
- Contract number
- SPE2DB25FAXL6
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $44,903
Award facts
- Contract value 100% obligated
- $44,902.62 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency (DLA) awarded a $44,902.62 delivery order to AmerisourceBergen Drug Corp on May 27, 2025, for the supply of Entresto 97 mg-103 mg tablets (180-count units). This is a firm fixed-price, competitively awarded contract with no set-aside designation and a completion date of May 28, 2025. AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, will perform the work at its corporate office location. This delivery order is issued under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), valued at $999,999,999.00 and extending through December 2026, which serves as the primary vehicle for supplying pharmaceuticals and medical supplies to support military healthcare programs globally.
AmerisourceBergen maintains an extensive federal contracting portfolio with DLA, supplying a comprehensive range of pharmaceutical products across multiple therapeutic domains to support Defense Health Agency and other federal healthcare systems. The company's demonstrated capability to compete successfully in open procurement and fulfill orders ranging from minimal to substantial values underscores its role as a critical vendor within the federal medical supply chain. Entresto, a cardiac medication used in heart failure treatment, represents one of the specialized pharmaceutical commodities procured through this contract vehicle to support military and veteran healthcare requirements.
Quick answers
Who was awarded contract SPE2DB25FAXL6?
SPE2DB25FAXL6 was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on May 27, 2025.
How much is contract SPE2DB25FAXL6 worth?
The government has obligated $44,903 on SPE2DB25FAXL6.
Is contract SPE2DB25FAXL6 an order under another contract?
Yes. SPE2DB25FAXL6 is a delivery order under SPE2DB22D3016, an indefinite delivery contract.
Was contract SPE2DB25FAXL6 competed?
The extent of competition for SPE2DB25FAXL6 was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award